Novel formulations of tumour-associated peptides binding to...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2665510

The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal and brain cancer, in particular glioma, especially glioblastoma cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel formulations of tumour-associated peptides binding to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel formulations of tumour-associated peptides binding to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel formulations of tumour-associated peptides binding to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2084333

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.